S&P 500   4,594.58 (-1.30%)
DOW   34,684.68 (-1.28%)
QQQ   398.63 (-0.27%)
AAPL   164.20 (+2.47%)
MSFT   335.68 (-0.28%)
FB   332.95 (-1.50%)
GOOGL   2,894.57 (-0.55%)
AMZN   3,555.00 (-0.18%)
TSLA   1,159.74 (+2.00%)
NVDA   329.25 (-1.35%)
BABA   128.94 (-2.03%)
NIO   40.48 (+0.05%)
CGC   10.77 (-2.62%)
AMD   162.18 (+0.17%)
GE   96.50 (-1.93%)
MU   86.08 (-0.07%)
T   22.99 (-3.77%)
F   19.67 (+0.00%)
DIS   145.98 (-1.24%)
ACB   6.39 (-0.78%)
AMC   35.21 (-4.42%)
PFE   53.81 (+2.69%)
BA   197.14 (-0.69%)
S&P 500   4,594.58 (-1.30%)
DOW   34,684.68 (-1.28%)
QQQ   398.63 (-0.27%)
AAPL   164.20 (+2.47%)
MSFT   335.68 (-0.28%)
FB   332.95 (-1.50%)
GOOGL   2,894.57 (-0.55%)
AMZN   3,555.00 (-0.18%)
TSLA   1,159.74 (+2.00%)
NVDA   329.25 (-1.35%)
BABA   128.94 (-2.03%)
NIO   40.48 (+0.05%)
CGC   10.77 (-2.62%)
AMD   162.18 (+0.17%)
GE   96.50 (-1.93%)
MU   86.08 (-0.07%)
T   22.99 (-3.77%)
F   19.67 (+0.00%)
DIS   145.98 (-1.24%)
ACB   6.39 (-0.78%)
AMC   35.21 (-4.42%)
PFE   53.81 (+2.69%)
BA   197.14 (-0.69%)
S&P 500   4,594.58 (-1.30%)
DOW   34,684.68 (-1.28%)
QQQ   398.63 (-0.27%)
AAPL   164.20 (+2.47%)
MSFT   335.68 (-0.28%)
FB   332.95 (-1.50%)
GOOGL   2,894.57 (-0.55%)
AMZN   3,555.00 (-0.18%)
TSLA   1,159.74 (+2.00%)
NVDA   329.25 (-1.35%)
BABA   128.94 (-2.03%)
NIO   40.48 (+0.05%)
CGC   10.77 (-2.62%)
AMD   162.18 (+0.17%)
GE   96.50 (-1.93%)
MU   86.08 (-0.07%)
T   22.99 (-3.77%)
F   19.67 (+0.00%)
DIS   145.98 (-1.24%)
ACB   6.39 (-0.78%)
AMC   35.21 (-4.42%)
PFE   53.81 (+2.69%)
BA   197.14 (-0.69%)
S&P 500   4,594.58 (-1.30%)
DOW   34,684.68 (-1.28%)
QQQ   398.63 (-0.27%)
AAPL   164.20 (+2.47%)
MSFT   335.68 (-0.28%)
FB   332.95 (-1.50%)
GOOGL   2,894.57 (-0.55%)
AMZN   3,555.00 (-0.18%)
TSLA   1,159.74 (+2.00%)
NVDA   329.25 (-1.35%)
BABA   128.94 (-2.03%)
NIO   40.48 (+0.05%)
CGC   10.77 (-2.62%)
AMD   162.18 (+0.17%)
GE   96.50 (-1.93%)
MU   86.08 (-0.07%)
T   22.99 (-3.77%)
F   19.67 (+0.00%)
DIS   145.98 (-1.24%)
ACB   6.39 (-0.78%)
AMC   35.21 (-4.42%)
PFE   53.81 (+2.69%)
BA   197.14 (-0.69%)
NASDAQ:AURA

Aura Biosciences News Headlines

$17.58
-0.17 (-0.96%)
(As of 11/30/2021 10:30 AM ET)
Add
Compare
Today's Range
$17.58
$18.38
50-Day Range
N/A
52-Week Range
$14.00
$26.16
Volume
579 shs
Average Volume
184,568 shs
Market Capitalization
$513.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Media Mentions By Week



Aura Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AURA
News Sentiment

0.51

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AURA Articles
This Week

13

22

AURA Articles
Average Week

Get Aura Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.

Aura Biosciences (NASDAQ:AURA) News Headlines Today

SourceHeadline
MarketBeat logoAura Biosciences (NASDAQ:AURA) Shares Gap Down to $22.62
americanbankingnews.com - November 29 at 1:14 PM
MarketBeat logoAura Biosciences (NASDAQ:AURA) Trading Up 4.6%
americanbankingnews.com - November 26 at 12:38 PM
nasdaq.com logoAura Biosciences’ Q3 Loss Widens
nasdaq.com - November 26 at 7:00 AM
MarketBeat logoResearch Analysts Offer Predictions for Aura Biosciences Inc's Q3 2021 Earnings (NASDAQ:AURA)
americanbankingnews.com - November 25 at 7:34 AM
finance.yahoo.com logoAura Biosciences Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
finance.yahoo.com - November 24 at 5:40 PM
MarketBeat logoAura Biosciences (NASDAQ:AURA) Shares Gap Up to $17.95
americanbankingnews.com - November 24 at 11:58 AM
finance.yahoo.com logoAura Biosciences Presents Final Phase 1b/2 Data for its first Virus-Like Drug Conjugate, AU-011, in Patients with Choroidal Melanoma at the American Academy of Ophthalmology 2021 Annual Meeting
finance.yahoo.com - November 23 at 4:38 PM
finance.yahoo.com logoAura Biosciences to Participate at the 4th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 23 at 4:38 PM
MarketBeat logoSVB Leerink Initiates Coverage on Aura Biosciences (NASDAQ:AURA)
americanbankingnews.com - November 23 at 10:40 AM
MarketBeat logoAura Biosciences (NASDAQ:AURA) Shares Down 13.3%
americanbankingnews.com - November 23 at 9:14 AM
MarketBeat logoBTIG Research Begins Coverage on Aura Biosciences (NASDAQ:AURA)
americanbankingnews.com - November 23 at 8:38 AM
MarketBeat logoAura Biosciences (NASDAQ:AURA) Now Covered by Evercore ISI
americanbankingnews.com - November 23 at 8:03 AM
MarketBeat logoAura Biosciences (NASDAQ:AURA) Earns Outperform Rating from Analysts at Cowen
americanbankingnews.com - November 23 at 8:03 AM
Get Aura Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.